ClinicalTrials.gg
Not yet recruitingNCT07361627CIME_upperlimbUpdated Nov 12, 2026

Upper Limb Rehabilitation Using Non-invasive Spinal Cord Stimulation

An interventional study of Protocol 1: Combination of activity-based therapy and sham spinal cord stimulation and Protocol 2: Combination of activity-based therapy and facilitatory transcutaneous spinal cord stimulation in Spinal Cord Injury Cervical, Spinal Cord Injury, Acute and Spinal Cord Injury (Quadraplegia), sponsored by Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal. Not yet recruiting at 1 site in Canada. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal · Not applicable, Interventional, and Treatment

How we know

Updated Nov 12, 2026Start date movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 204 studies in Spinal Cord Injuries with a site in Canada — 67 open to participants now, 74 under way, 4 of them phase 3. Spinal Cord Injuries · Canada.

Planned enrollment
54th of 179
40 · median 24
Started
2027
with 6 others
No phase
127 of 204
52 open now
Primary completion
2028-08
later than 57 of 73 live
Registered
186th of 204
by date

Among the 204 studies in Spinal Cord Injuries with a site in Canada, this one is the 54th largest by planned enrollment of the 179 interventional ones that give a count, is one of 7 that started in 2027, is one of 127 with no phase, reaches primary completion later than 57 of the 73 other live ones, and was the 186th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

67 of the 204 studies in Spinal Cord Injuries with a site in Canada are open now. Recruiting first, the newest first:

62 more — sign in →

All 67 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 16 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 204 studies in Spinal Cord Injuries with a site in Canada, or all of them as a file.
02

Study summary

The goal of this RCT study is to evaluate if combining activity-based therapy (ABT) with transcutaneous spinal cord stimulation (tSCS) can improve recovery of arm and hand movement in people with cervical spinal cord injury (SCI). As secondary aims, the study will also investigate at how this combination approach affects the cortical changes in the somatosensory and motor areas of the brain, as well as in the spinal cord and whether it helps participants use their arms more in daily life.

The main questions relevant to this study are:

  1. Can the combination of ABT + tSCS improve motor and sensory functions of the arms and hands more than ABT alone during the sub-acute stage after SCI?
  2. Does ABT + tSCS induce neuroplasticity, that is, changes in the brain and spinal cord activity linked to motor and sensory functions?
  3. Do participants who receive ABT + tSCS report greater use of their arms in daily activities compared to those who receive ABT only?

In this study, participants will:

  • Receive either ABT + tSCS or ABT + sham stimulation (a low-intensity current that does not facilitate the movements)
  • Take part in 20 training sessions over 6-8 weeks (3 times per week, 45 min of active training each). During this, they will perform strengthening, task-based training, and motor control strengthening exercises with a therapist.
  • Complete clinical tests and neurophysiological assessments (transspinal electrical stimulation, electroencephalography and transcranial magnetic stimulation) at three time points-- at the start, after training, and one month later to measure recovery and brain activity changes.

Researchers will compare the assessment outcomes across the three time points.

Read the detailed description

This RCT study is led by Dorothy Barthélemy (Ph.D, pht, Principal Investigator (PI)), Marika Demers (Ph.D, erg., co-PI), Diana Zidarov (Ph.D, co-PI) and Sujata Sinha (PhD, postdoctoral fellow, project lead). Collaborator includes Victoria Duda (PhD).

Population: individuals with SCI with injury level between C5 and T2, falling into American Spinal Injury Association (ASIA) categories A to D, in the sub-acute phase, and of minimum age of 16 years. These participants are in-patients admitted in the Institut de réadaptation Gingras-Lindsay de Montréal, Canada.

Participants will be randomized (1:1 ratio) into two equal groups, ABT + tSCS and ABT + sham stimulation and stratified based on ASIA level, age and sex.

During the training session, the ABT + tSCS group will receive ABT combined with tSCS. The tSCS will be delivered using surface electrode placed between C4 and T1 as a cathode and self-adhesive surface electrodes placed in the clavicular region on both sides as anodes. tSCS will deliver tonic pulses (30 - 100 Hz) and at an intensity that facilitates voluntary movements (usually 15 mA and up), determined prior to the first training session. Each ABT session will include 5 parts:

  1. 'Motor control strengthening: equipped with an electronic goniometer, participants control muscle contraction of one joint by following a pattern on a computer screen.
  2. Cardiovascular warm-up exercises: using equipment that will allow the participant to train their cardiovascular system.
  3. Weight bearing and stretching exercises: exercises to prepare their upper body muscles for the strengthening exercises.
  4. Muscle strengthening exercises: exercises to increase their strength, with adapted equipment if necessary.
  5. Activity-based exercises: exercises composed of repetitive that are present in the participant's daily life.

In the ABT+ sham stimulation group, intensity will be set at sensory threshold that will not facilitate any movement (usually 2-3mA). The ABT will be similar to the other group.

Prior to the training, clinical tests will be conducted to assess assess their muscle strength, sensations, and the quality of movements participants can make with their arms. Specifically, the primary measure will consist of the Upper Extremity Motor Score from the with American Spinal Injury Association Impairment Exam. The secondary clinical measures will include the following assessments: the Prehension subtest of the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP-version 2) , Monofilaments test, Sensory function of the upper limb dermatomes from C4 to T1, Grip and pinch strength with a dynamometer, Proprioception subtest of the Fugl Meyer Assessment, the finger-to-nose test and the Tetraplegic Upper Limb Activity Questionnaire (TUAQ). More details of the measures are in the Outcome Measures section.

For neurophysiological measures, electrophysiological assessments will include transspinal evoked potential (TEP), motor evoked potentials (MEPs) using transcranial magnetic stimulation (TMS) and somatosensory evoked potentials (SSEPs) using electroencephalogram (EEG).

These assessments will be conducted before the training, immediately after the training and one month later.

As for the experiment, 40 participants will be recruited, as determined by a priori power analysis.

For the neuroplasticity evaluation, TEP, TMS and EEG will be used.

  1. To assess the excitability of spinal pathways, the non-invasive procedure of single-pulse transcutaneous spinal stimulation (tSCS) will be used. Participants will be comfortably seated in a chair or in their wheelchair. Self-adhesive surface electrodes will be placed over the cervical spine, with the cathode (Dura stick plus double wire, Dura stick, USA) over C4-T1 and anodes over the external part of the clavicles (TENS electrodes, ROHVEMJ). Single-pulse tSCS will be delivered using a constant-current stimulator (DS8R, Digitimer, UK) to induce Transspinal evoked potentials (TEPs). Responses will be recorded from surface electromyography. More details of the measurement are in the Outcome Measures section.
  2. To assess changes along the corticospinal tract (motor cortex projections to the spinal cord), a magnetic field using the TMS will be applied to the primary motor cortex (M1) over the representation area of the contralateral bicep brachii muscle (this is the target muscle). This response will be recorded painlessly using surface electromyography (EMG) electrodes placed over the targeted muscle. The entire evaluation, including setup, will take approximately one hour. The responses evoked by TMS, that is, the motor evoked potentials, (MEPs) will be compared across the 3 time frames in each group. Particularly, latency and peak-to-peak amplitude of MEPs will be measured. More details of the measurement are in the Outcome Measures section. Participants with specific contraindications to TMS (epilepsy, non-union cranial fracture and increased intracranial pressure) will be able to participate in the study, but will not take part in the TMS assessment..

2. To assess changes in brain mechanisms, particularly those related to sensory function, EEG recordings will be performed using Brain Vision's 32-electrode cap, with the Fz electrode used as the reference. Recordings will be obtained using a Brain Vision 32-channel EEG cap referenced to Fz. The median nerve of the upper limb (at the wrist site) will be electrically stimulated to elicit cortical responses. The entire evaluation duration will be for 90 minutes including the setup.

EEG activity from C3 and C4 corresponding to the contralateral sensorimotor cortex, will be analyzed, focusing on the N20 and P25 somatosensory evoked potential (SSEP) components, which occur approximately 20 ms and 25 ms post-stimulus, respectively. The N20-P25 complex reflects transmission through ascending somatosensory pathways.

N20 refers to the negative-deflecting SSEP peaking approximately 20 ms after the onset of electrical stimulation at the median nerve. P25 follows the N20, deflecting in a positive direction peaking around 25 ms after stimulus onset. Together, these form the N20-P25 complex, which reflects the transmission along ascending neuronal pathways. In addition to these two SSEPs that occur in the early time-window, P50 and the N70 SSEPs that peak approximately around 50ms and 70 ms , respectively, after the stimulus onset. The amplitude and latency of the SSEPs will be compared across the 3 time frames in each group. In addition to C3 and C4, the neighboring electrode regions will also be inspected to identify any additional SSEPs that may emerge. More details of the measurement are in the Outcome Measures section.

03

Conditions studied

  • Spinal Cord Injury Cervical
  • Spinal Cord Injury, Acute
  • Spinal Cord Injury (Quadraplegia)

Keywords

  • Spinal cord injury
  • Sub-acute
  • Neuromodulation
  • transcutaneous Spinal Cord Stimulation
  • Activity-based therapy
  • Upper extremity motor score
  • Rehabilitation
  • Electroencephalography
  • EEG
  • Somatosensory evoked potential
  • Transcranial Magnetic Stimulation
  • Motor evoked potential
  • Clinical assessment
  • Neuroplasticity
04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Traumatic and non-traumatic spinal cord injury
  • Receiving in-patient rehabilitation
  • 16 years old or above
  • American Spinal Injury Association (ASIA) grade A to D
  • Neurological injury level between C5 and T2
  • Residual upper limb motor impairments

Exclusion criteria

Exclusion Criteria:

  • Cardiac pacemaker
  • Active cancer at the stimulation site or cancer
  • Unstable lesion or clinical condition (e.g. respiratory issues)
  • Electrode placement is impossible due to unhealed wound or significant local pain
  • Other Neurological condition (e.g. Stroke, Parkinson's)
  • Chronic liver or kidney disease
  • Uncontrolled psychiatric condition
  • \< 6 months
  • Inability to provide (i.e., severe cognitive impairment, dementia, or Alzheimer's disease)
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Sham comparator
    Activity-based therapy with sham spinal stimulation (n=20)

    Participants with cervical spinal cord injury (ASIA levels A-D) randomized to this arm will receive sham transcutaneous spinal cord stimulation combined with activity-based therapy. Training will consist of 20 sessions delivered over 6-8 weeks during the subacute stage. For the transcutaneous spinal cord stimulation (tSCS), a single or two self-adhesive cathode electrodes will be placed at the C4 to T1 vertebral levels. A pair of reference electrodes will be placed bilaterally on the external part of the clavicular regions. The stimulation will be set at minimal intensity, sufficient only for the participants to perceive it.

    Other: Protocol 1: Combination of activity-based therapy and sham spinal cord stimulation

  • Experimental
    Activity-based therapy with facilitatory spinal stimulation (n=20)

    Participants with cervical spinal cord injury (ASIA levels A-D) randomized to this arm will receive real-intensity transcutaneous spinal cord stimulation combined with activity-based therapy. Training will consist of 20 sessions delivered over 6-8 weeks during the subacute stage. For the transcutaneous spinal cord stimulation (tSCS), a single or two self-adhesive cathode electrodes will be placed at the C4 to T1 vertebral levels. A pair of reference electrodes will be placed bilaterally on the external part of the clavicular regions. The stimulation will be set at minimal intensity, sufficient only for the participants to perceive it. Individualized tSCS parameters (30-80Hz, 0-90mA, biphasic 400us pulse square) will be used to facilitate upper limb movement.

    Other: Protocol 2: Combination of activity-based therapy and facilitatory transcutaneous spinal cord stimulation

Interventions

  • OtherProtocol 1: Combination of activity-based therapy and sham spinal cord stimulation

    The training session for the sham group comprises of activity-based therapy along with sham stimulation on the spinal cord of the participants. These training sessions will include repetitive, intensive strength training and functional exercises targeting arm and hand (upper limb) movements. Sessions will be delivered by trained physiotherapists and occupational therapists. Each participant will complete 20 sessions over six to eight weeks (three per week), with each session lasting 45 minutes. Breaks will be added, if needed. Training will consist of cardiovascular training, stretching, weight-bearing, strengthening and controlled strengthening and task-oriented training. Participants will receive transcutaneous spinal cord stimulation set at sensory threshold intensity (i.e., below the threshold that facilitates voluntary movement of the limb; usually 2-3 mA intensity), delivered simultaneously with training.

    Also known as: Sham stimulation

  • OtherProtocol 2: Combination of activity-based therapy and facilitatory transcutaneous spinal cord stimulation

    The training session for the experimental group comprises of activity-based therapy along with facilitatory stimulation on the spinal cord of the participants. These training sessions will include repetitive, intensive strength training and functional exercises targeting arm and hand (upper limb) movements. Sessions will be delivered by trained physiotherapists and occupational therapists. Each participant will complete 20 sessions over six to eight weeks (three per week), with each session lasting 45 minutes. Breaks will be added, if needed. Training will consist of cardiovascular training, stretching, weight-bearing, strengthening and controlled strengthening and task-oriented training. Participants will receive transcutaneous spinal cord stimulation set at a target intensity that facilitates voluntary upper limb movement (usually between 10 and 25 mA) in the participants.

    Also known as: tSCS

06

What researchers measure

Primary outcomes

  1. Upper Extremity Motor Score (UEMS)

    This will be used for assessing the motor function, that is, the strength and functionality of the muscles involved in movement. It helps determine the severity of motor impairments in patients with cervical lesions and is used to track recovery and assess outcome during inpatient rehabilitation. It has high inter-rater and intra-rater reliability. It also has high validity as an impairment measure and has moderate validity for predicting real-world functional independence. The test evaluates five movements of each arm, namely, elbow flexion, wrist extension, elbow extension, middle finger flexion, and little finger abduction. The participant is asked to perform these movements either actively or passively, depending on their ability. These are scored on a scale from 0 (no movement) to 5 (full function). Thus, the higher score reflects improvement in the motor function across the three time frames.

    Time frame: 3 time points: Pre-intervention (Day 0, prior to the first training session), Post-intervention (+/-1 week) and one-month post-intervention (+/- 1 week).

Secondary outcomes

  1. The Prehension subtest of the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP- version 2)

    This test will be used to assess the hand function in participants, particularly their grasping ability and object manipulation. This includes two components: prehension ability (PA) and prehension performance (PP). PA evaluates the capacity to perform different grasp patterns, including cylindrical, lateral pinch, and tip pinch grasps. Each hand is assessed separately and scored on a scale from 0 to 4, with 4 being the normal voluntary control of the wrist and fingers during grasp execution. PP assesses the ability to complete functional tasks requiring grasp, manipulation, and release of objects of various shapes and sizes. Each hand is evaluated separately, and task performance is scored from 0 to 5, with 5 being the most successful task completion using the intended grasp pattern. Higher total scores indicate better hand function and prehension ability. The subtest has excellent test-retest reliability (ICC = 0.93-0.98) and excellent inter-rater reliability (ICC = 0.95-0.96).

    Time frame: 3 time points: Pre-intervention (Day 0, prior to the first training session), Post-intervention (+/-1 week) and one-month post-intervention (+/- 1 week).

  2. Upper-limb sensory score of the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)

    This will be used to assess the sensory level of the participant by evaluating the ability to feel stimuli and to differentiate between sharp and dull sensations (pinprick test) on specific regions of the skin corresponding to spinal nerve segments. The summed sensory scores (light touch + pinprick) have good to excellent inter- and intra-rater reliability. So, we will use the summed scores. The test has good validity for classifying lesion level and severity, moderate for predicting function, and has limited sensitivity (not sensitive to subtle changes) compared to electrophysiological or quantitative tests. Light touch and pinprick sensation are first demonstrated on the participant's cheek. The participant, seated with eyes closed, is tested using light touch with tissue or cotton (assessing large A fibers) and pinprick with a pin or toothpick (assessing smaller A-delta and C fibers for superficial pain) at six test sites. The sensation is reported by them.

    Time frame: 3 time points: Pre-intervention (Day 0, prior to the first training session), Post-intervention (+/-1 week) and one-month post-intervention (+/- 1 week).

  3. Monofilament test

    This will be used to quantify and to assess the sensory function, particularly for detecting areas of sensory loss or abnormal sensation (neuropathic pain). This test has high validity and inter-and intra tester reliability in participants with chronic cervical spinal cord injury. The test is conducted using Semmes-Weinstein monofilaments. With eyes closed, the participant is asked to report whether they can feel the pressure when a monofilament is applied to different regions of the upper limb. The threshold at which the stimulus is perceived is recorded (5.88, 5.07, 4.56, 4.08, 3.22). Specific regions are assessed depending on the nerve: the pulp of the middle finger for the median nerve, the pulp of the little finger for the ulnar nerve, the first dorsal space of the hand between the thumb and index finger and the lateral epicondyle at the extensor compartment for the radial nerve, and the deltoid region for the axillary nerve.

    Time frame: 3 time points: Pre-intervention (Day 0, prior to the first training session), Post-intervention (+/-1 week) and one-month post-intervention (+/- 1 week).

  4. Force (Grip and Pinch Strength) test

    This will be used to assess grip and pinch strength which are used in daily tasks involving hand function. The Pinch strength test has good to excellent reliability for neurological conditions and has strong to very strong correlations with grip strength. It has a good validity. The Grip strength has an excellent test-retest reliability in SCI. It shows a very high intra- and inter-rater reliability if standardized protocols (same dynamometer, position, instructions) are followed. It has a good validity. Grip strength is measured using a dynamometer, with the participant seated and the elbow flexed at 90 degrees. The participant must squeeze the device as hard as possible for 3 trials; the average of these trials is calculated. Pinch strength is measured using a pinch gauge, where the participant pinches an object between the thumb and index finger with maximum effort. Again, the average of 3 trials is taken.

    Time frame: 3 time points: Pre-intervention (Day 0, prior to the first training session), Post-intervention (+/-1 week) and one-month post-intervention (+/- 1 week).

  5. Proprioception

    This test is used to the assess the ability to sense the position of the limbs in space, important for evaluating proprioceptive deficits that can affect balance and coordination. It has a moderate overall and inter-rater reliability and depends strongly on the therapist's technique. Intra-rater reliability is better but is variable as participants can have fatigue or guess. Test-retest reliability is lower than that of dermatomes or motor scores. It has a limited validity; construct validity is supported and concurrent validity shows moderate correlation with function; criterion validity is limited. The participant is blinded while the therapist moves their upper limb (shoulder, elbow, and wrist) to a specific position and asks them to replicate the position with the opposite limb or to report the position. Results are reported as the difference between the actual and replicated positions.

    Time frame: 3 time points: Pre-intervention (Day 0, prior to the first training session), Post-intervention (+/-1 week) and one-month post-intervention (+/- 1 week).

  6. Coordination test

    This test is used to assess the ability to perform smooth, controlled movements, critical for fine motor tasks (e.g. writing, buttoning a shirt). Its reliability is generally low to moderate: intra-rater reliability is variable as it depends on the therapist scoring, inter-rater reliability is moderate at best, and test-retest reliability is limited since coordination can fluctuate with fatigue, spasticity, or attention. Validity is also limited, with moderate construct validity, low to moderate concurrent validity, and limited criterion validity. The standard finger-to-nose test is used: the participant is asked to touch a target with the index finger and then their nose, repeating the movement five times at a fast but comfortable pace. The therapist observes for tremors, uncoordinated movements, delays, and scores performance using a 12-point scale per side that considers precision, fluidity, arm movement, and trunk stability.

    Time frame: 3 time points: Pre-intervention (Day 0, prior to the first training session), Post-intervention (+/-1 week) and one-month post-intervention (+/- 1 week).

  7. Transspinal evoked potentials (TEPs)

    TEPs will be measured through single-pulse transcutaneous spinal stimulation (tSCS). The cathode (Dura stick plus double wire, Dura stick, USA) will be positioned at the midline over C4-T1 and anode over the external part of the clavicles (TENS electrodes, ROHVEMJ). Single-pulse tSCS will be delivered using a constant-current stimulator (DS8R, Digitimer, UK) with monophasic square-wave pulses of 1ms at a frequency of 0.2Hz to induce TEPs. Responses will be recorded from surface electromyography. Stimulation intensity will be gradually increased from 0 to evoke a potential in all, or in the maximum number of upper limb muscles recorded. Two of the outcome measures will be for each muscle: the motor threshold, i.e., the lowest intensity inducing 5/10 stimulation responses; and the recruitment curve. The third measure will include amplitude, latency, and duration of the TEP at 120% of the motor threshold, determined for the myotome that showed the smallest response.

    Time frame: 3 time points: Pre-intervention (Day 0, prior to the first training session), Post-intervention (+/-1 week) and one-month post-intervention (+/- 1 week).

  8. Transcranial magnetic stimulation (TMS)- motor evoked potentials

    This neurophysiological assessment will be done to test if there are neuroplastic changes because of the ABT + tSCS training. TMS will be applied to the primary motor cortex (M1) over the representation area of the contralateral bicep brachii muscle (this is the target muscle). A figure-8 shaped coil will deliver the magnetic field to activate motor nerves, leading to the activation of the target muscle. This response will be recorded painlessly using surface electromyography electrodes placed over the targeted muscle. Four 5-minute stimulation sets, each separated by 2-minute rest periods, will be conducted. The entire evaluation, including setup, will take approximately one hour. The responses evoked by TMS, that is, the motor evoked potentials, (MEPs) will be compared across the 3 time frames in each group. Quantitative parameters will include MEP amplitude (magnitude), and latency, serving as indicators of cortico-spinal excitability changes pre- and post-intervention.

    Time frame: 3 time points: Pre-intervention (Day 0, prior to the first training session), Post-intervention (+/-1 week) and one-month post-intervention (+/- 1 week).

  9. Electrophysiology (EEG)-Somatosensory evoked potentials (SSEPs)

    This test will also be done for neuroplastic evaluation. SSEPs are time-locked EEG responses reflecting sensory pathway conduction from peripheral nerves to the somatosensory cortex. Participants will be comfortably seated in a chair. For each arm, the median nerve will be stimulated using surface electrodes placed near the wrist to elicit upper-limb SSEPs. EEG will be recorded with a 32-channel cap (Brain Vision Recorder 2.0) following the 10-20 system, referenced to Fz. During a 10-minute session for each arm, 1800 stimuli (3 Hz, 0.001 s duration) will be delivered at 5% of the maximal flexor carpi radialis response. EEG signals will be sampled at 5000 Hz and analyzed in BrainVision Analyzer using filtering and averaging. Primary regions of interest include C3/C4 and adjacent electrodes (Cz, C1/2, FCz). The expected SSEPs are N20 (\~20 ms) and P25 (\~25 ms). The presence, amplitude, and latency of the N20-P25 complex will serve as measures of somatosensory pathway excitability.

    Time frame: 3 time points: Pre-intervention (Day 0, prior to the first training session), Post-intervention (+/-1 week) and one-month post-intervention (+/- 1 week).

07

Study locations

1 site
08

References and documents

Publications

  • Lynskey JV, Belanger A, Jung R. Activity-dependent plasticity in spinal cord injury. J Rehabil Res Dev. 2008;45(2):229-40. doi: 10.1682/jrrd.2007.03.0047. PubMed 18566941 ↗
  • Steele AG, Manson GA, Horner PJ, Sayenko DG, Contreras-Vidal JL. Effects of transcutaneous spinal stimulation on spatiotemporal cortical activation patterns: a proof-of-concept EEG study. J Neural Eng. 2022 Jul 1;19(4). doi: 10.1088/1741-2552/ac7b4b. PubMed 35732141 ↗
  • Manson G, Atkinson DA, Shi Z, Sheynin J, Karmonik C, Markley RL, Sayenko DG. Transcutaneous spinal stimulation alters cortical and subcortical activation patterns during mimicked-standing: A proof-of-concept fMRI study. Neuroimage Rep. 2022 Jun;2(2):100090. doi: 10.1016/j.ynirp.2022.100090. Epub 2022 Mar 8. PubMed 36212800 ↗
  • Dimitrijevic MR, Illis LS, Nakajima K, Sharkey PC, Sherwood AM. Spinal cord stimulation for the control of spasticity in patients with chronic spinal cord injury: II. Neurophysiologic observations. Cent Nerv Syst Trauma. 1986 Spring;3(2):145-52. doi: 10.1089/cns.1986.3.145. PubMed 3490313 ↗
  • Sadowsky CL, McDonald JW. Activity-based restorative therapies: concepts and applications in spinal cord injury-related neurorehabilitation. Dev Disabil Res Rev. 2009;15(2):112-6. doi: 10.1002/ddrr.61. PubMed 19489091 ↗
  • Murray LM, Knikou M. Transspinal stimulation increases motoneuron output of multiple segments in human spinal cord injury. PLoS One. 2019 Mar 7;14(3):e0213696. doi: 10.1371/journal.pone.0213696. eCollection 2019. PubMed 30845251 ↗
  • Kalsi-Ryan S, Beaton D, Curt A, Popovic MR, Verrier MC, Fehlings MG. Outcome of the upper limb in cervical spinal cord injury: Profiles of recovery and insights for clinical studies. J Spinal Cord Med. 2014 Sep;37(5):503-10. doi: 10.1179/2045772314Y.0000000252. PubMed 25229734 ↗
  • Wuolle KS, Van Doren CL, Thrope GB, Keith MW, Peckham PH. Development of a quantitative hand grasp and release test for patients with tetraplegia using a hand neuroprosthesis. J Hand Surg Am. 1994 Mar;19(2):209-18. doi: 10.1016/0363-5023(94)90008-6. PubMed 8201183 ↗
  • Velstra IM, Bolliger M, Baumberger M, Rietman JS, Curt A. Epicritic sensation in cervical spinal cord injury: diagnostic gains beyond testing light touch. J Neurotrauma. 2013 Aug 1;30(15):1342-8. doi: 10.1089/neu.2012.2828. PubMed 23895137 ↗
  • Sullivan KJ, Tilson JK, Cen SY, Rose DK, Hershberg J, Correa A, Gallichio J, McLeod M, Moore C, Wu SS, Duncan PW. Fugl-Meyer assessment of sensorimotor function after stroke: standardized training procedure for clinical practice and clinical trials. Stroke. 2011 Feb;42(2):427-32. doi: 10.1161/STROKEAHA.110.592766. Epub 2010 Dec 16. PubMed 21164120 ↗
  • Molad R, Alouche SR, Demers M, Levin MF. Development of a Comprehensive Outcome Measure for Motor Coordination, Step 2: Reliability and Construct Validity in Chronic Stroke Patients. Neurorehabil Neural Repair. 2021 Feb;35(2):194-203. doi: 10.1177/1545968320981943. PubMed 33410389 ↗
  • Tefertiller C, Rozwod M, VandeGriend E, Bartelt P, Sevigny M, Smith AC. Transcutaneous Electrical Spinal Cord Stimulation to Promote Recovery in Chronic Spinal Cord Injury. Front Rehabil Sci. 2021;2:740307. doi: 10.3389/fresc.2021.740307. Epub 2022 Jan 4. PubMed 36004322 ↗
  • Gopaul U, Bayley MT, Kalsi-Ryan S. Combined Activity-Based Therapy and Cervical Spinal Cord Stimulation: Active Ingredients, Targets and Mechanisms of Actions to Optimize Neurorestoration of Upper Limb Function After Cervical Spinal Cord Injury. Physiother Res Int. 2025 Apr;30(2):e70036. doi: 10.1002/pri.70036. PubMed 39927575 ↗
  • Mulcahey MJ, Betz RR, Kozin SH, Smith BT, Hutchinson D, Lutz C. Implantation of the Freehand System during initial rehabilitation using minimally invasive techniques. Spinal Cord. 2004 Mar;42(3):146-55. doi: 10.1038/sj.sc.3101573. PubMed 15001979 ↗
  • Marino RJ, Jones L, Kirshblum S, Tal J, Dasgupta A. Reliability and repeatability of the motor and sensory examination of the international standards for neurological classification of spinal cord injury. J Spinal Cord Med. 2008;31(2):166-70. doi: 10.1080/10790268.2008.11760707. PubMed 18581663 ↗
  • Demers M, Hoang Quang N, Chesne L, Sinha S, Dube N, Bourgeois H, Zidarov D, Meftah EM, Desbarbieux AC, Restout J, Law NY, Ceglia A, Barthelemy D; CIME upper limb rehab team. Combined activity-based therapy and transcutaneous spinal cord stimulation as an intensification and supplemental approach for upper limb sensorimotor recovery: a randomised controlled trial protocol for in-patients with subacute spinal cord injury. BMJ Open. 2026 Aug 14;16(8):e117320. doi: 10.1136/bmjopen-2026-117320. PubMed 42601092 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Aug 2028, 19 months later.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 19 months is below that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Jan 2027, on Nov 12, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 23, 2025
First posted
Jan 23, 2026
StartEst.
Jan 1, 2027was Sep 2026
Primary completionEst.
Aug 31, 2028
CompletionEst.
Dec 9, 2028
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Sep 1, 2026→Jan 1, 2027
Nov 12, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 42601092 ↗
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 42601092 ↗
    Start date Sep 1, 2026→Jan 1, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07361627
Lead sponsor
Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal
Responsible party
Sponsor
First posted
Jan 23, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Aug 31, 2028 (estimated)
Completion
Dec 9, 2028 (estimated)
Last update
Nov 12, 2026

Study contacts

Dorothy Barthelemy, pht., Ph.D
Contact
dorothy.barthelemy@umontreal.ca
+1 514-343-6111 ext. 13962
Marika Demers, erg., Ph.D
Contact
marika.demers@umontreal.ca
514-343-6111 ext. 30897
Dorothy Barthelemy, pht., PhD
principal investigator · Université de Montréal

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion